DAPTOMYCIN, 13-((.ALPHA.S)-.ALPHA.-AMINO-2-(FORMYLAMINO)-.GAMMA.-OXOBENZENEBUTANOIC ACID)-
UNII ZW3T668STW

Substance Identification & Data

This profile provides standardized clinical and technical data for Daptomycin, 13-((.alpha.s)-.alpha.-amino-2-(formylamino)-.gamma.-oxobenzenebutanoic Acid)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZW3T668STW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 856000-07-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZW3T668STW

CAS Registry Number

856000-07-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAPTOMYCIN, 13-((.ALPHA.S)-.ALPHA.-AMINO-2-(FORMYLAMINO)-.GAMMA.-OXOBENZENEBUTANOIC ACID)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C73H101N17O27

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RREUOCHQEZVHQU-AMHMBKJNSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

176489873

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C([C@@H](C(N[C@@H](C(N[C@H](C(N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2c(NC=O)cccc2)NC(=O)[C@]([C@@H](CC(O)=O)C)(NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[H])=O)CC(O)=O)=O)CC(N)=O)=O)NC(CCCCCCCCC)=O)c3c4c([nH]c3)cccc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Daptomycin, 13-((.alpha.s)-.alpha.-amino-2-(formylamino)-.gamma.-oxobenzenebutanoic Acid)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.